Navigation Links
China Non-Small Cell Lung Cancer Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
Date:9/21/2013

Dallas, TX (PRWEB) September 22, 2013

Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered on chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.

Complete report is available at http://www.rnrmarketresearch.com/pharmapoint-non-small-cell-lung-cancer-china-drug-forecast-and-market-analysis-to-2022-market-report.html.

This report estimates that branded NSCLC market in China will grow in the forecast period. This increase will be due largely to an increasing aging population; increased use of EGFR and ALK targeted therapies and increased numbers of people covered by private health insurance.

Scope
Overview of NSCLC including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in China including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in China from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting China NSCLC market.

Reasons to Buy

  • Understand and Capitalize by Identifying Products That Are Most Likely to Ensure a Robust Return
  • Stay ahead of the competition by understanding the changing competitive landscape for NSCLC
  • Effectively Plan Your M&A and Partnership Strategies by Identifying Drugs With the Most Promising Sales Potential
  • Make More Informed Business Decisions from Insightful and In-Depth Analysis of Drug Performance
  • Obtain Sales Forecast for Drugs from 2012-2022 in China

Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=114312.

Browse more reports on Respiratory Therapeutics Market http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/respiratory-therapeutics.

Contact sales (at) rnrmarketresearch (dot) com for further information.

About Us:

RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/china-non-small-cell-lung/drug-market-report/prweb11145242.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. China Human Rabies Vaccine Industry 2013 Analysis & 2017 Forecasts in New Research Report at RnRMarketResearch.com
2. 2013 China Medical Insurance Inflation Rates Revealed
3. China Poultry Vaccine Market Analysis
4. China Orthopedic Instrument Market 2013 Analysis & 2015 Forecasts in New Research Report at RnRMarketResearch.com
5. Medical Device Manufacturing in China Industry Research Report – Now Available from IBISWorld
6. China Independent Clinical Laboratory Industry Report, 2013-2015: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2015
7. Autonomous Clinical Laboratory Market in China 2013 Analysis & 2015 Forecasts in New Report Now Available at RnRMarketResearch.com
8. China BCAAs Market (Branched-Chain Amino Acids) Suppy & Forecasts in a New Research at ReportsnReports.com
9. Artisan Business Group Announces EB-5 China Trade Mission Itinerary
10. China Water and Air Pollution Impacts Food Supply Reports Water Advocate Sharon Kleyne
11. New risk model highlights arsenic risk in Chinas groundwater
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , ... February 05, 2016 , ... ... setting the stage for new clinical and scientific initiatives have all marked the ... she was appointed President and CEO of the nation’s oldest cancer center, Candace ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... College President George H. Van Allen have signed a joint enrollment and degree ... a seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The ...
(Date:2/5/2016)... ... 05, 2016 , ... The American public tends to feel uncomfortable about drinking ... regular municipal or well water. The recent experience with lead contaminated water in Flint, ... long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... ... 05, 2016 , ... At its annual meeting held last week, the American ... National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We ... Chambers , APDA President and CEO. “Pat has tirelessly served APDA since 2001 when ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of the day ... feature of patients with eating disorders is significant self-criticism, and consequently these patients experience ... are regarded as maladaptive means for coping with this unease, but also leads to ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... CENTENNIAL, Colo. , Feb. 5, 2016  As ... about health. The multitude of recommended screenings and tests ... healthy aging a priority. However, for the majority of ... of proactive health planning. For the 37.5 million American ... time like the present to make hearing health a ...
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
Breaking Medicine Technology: